1 CD25 1 Tregs displayed significantly increased phagocytosis of chicken red blood cells (cRBCs) and arginase activity together with increased IL-10 production, whereas these macrophages also showed decreased immunogenicity and nitric oxide (NO) production. Blocking arginase partially but significantly reversed the effects of CD4 1 CD25 1 Tregs with regard to the induction of the M2 macrophages in vivo. Therefore, the allogeneic donor CD4
INTRODUCTION
Mononuclear phagocytes are an important part of innate immunity and are closely involved in pathogen and tissue debris clearance and in shaping the adaptive immune responses. 1, 2 In addition to acting as a first line of resistance against pathogens and activating adaptive responses, mononuclear phagocytes also undergo reprogramming of their functional properties in response to signals derived from microbes, damaged tissues and resting or activated lymphocytes in either physiological or pathological states. 3, 4 Mirroring T helper type 1 (Th1)-Th2 polarization, two distinct states of polarized activation for macrophages have been recognized: the classically activated (M1) and the alternatively activated (M2) macrophages. 5, 6 Th1 cells can drive classical M1 polarization of macrophages via interferon (IFN)-c. These M1 cells are characterized by their ability to release large amounts of pro-inflammatory cytokines, such as IL-12, IL-23 and tumor necrosis factor (TNF), reactive nitrogen intermediates and reactive oxygen intermediates, increased expression of MHC II and costimulatory molecules, efficient antigen presentation and microbicidal or tumoricidal activity. 7, 8 Through the expression of cytokines and chemokines, such as IL-12, CXCL9 and CXCL10, M1 macrophages drive the polarization and recruitment of Th1 cells, thereby amplifying a type 1 response. 9 The Th2 cell-derived cytokines, IL-4 and IL-13, direct M2 polarization of macrophages during helminth infection and allergy. Indeed, some prototypical mouse M2 markers, such as YM1, FIZZ1 and MGL, were identified during parasite infection and allergic inflammation. IL-4-or IL-10-treated macrophages displayed low expression of IL-12 and high expression of IL-10, IL-1 decoy receptor and IL-1RA and shared the features of M2 macrophages. 10, 11 M2 macrophages have been implicated in the control of CD4 1 T cell hyporesponsiveness via the induction of CD4 1 CD25 1 regulatory T cells (Tregs) or the inhibition of IL-17-producing CD4
1 T cells. 6, 12 Accordingly, different macrophage subsets may play distinct roles in modulating either the immune response or tolerance. It is now known that human CD4 1 CD25 1 Foxp3 1 Tregs can induce the alternative activation of human macrophages/monocytes in vitro. 13, 14 Our previous in vivo results showed that in severe combined immunodeficiency mice, the adoptive transfer of syngeneic CD4
1 CD25 1 Tregs into the peritoneal cavity polarizes F4/80 1 macrophages into an M2 phenotype.
Bone marrow transplantation is used in clinics to treat patients with leukemia or other relevant diseases. 16, 17 However, graft-versus-host disease remains a major barrier for the clinical application of HLAmismatched bone marrow transplantation. [18] [19] [20] The protective effect of donor CD4
1 CD25 1 Tregs in graft-versus-host disease has been previously demonstrated. 21, 22 In addition to the inhibition of T effector cells (Teffs) ) were purchased from the Beijing University Experimental Animal Center (Beijing, China) and the National Rodent Laboratory Animal Resources, Shanghai Branch (Shanghai, China). All mice were maintained in a specific pathogen-free facility and were housed in microisolator cages containing sterilized feed, autoclaved bedding and water. All experimental procedures were performed in accordance with the Institutional Guidelines for the Care and Use of Laboratory Animals.
Isolation and adoptive transfer of CD4
1 T-cell subsets
Enriched CD4
1 CD25 1 T-cell and CD4 1 CD25 2 T-cell populations were isolated from mouse splenocytes using either a CD4 1 CD25
1
Tregs isolation kit with the MidiMACS Separator according to the manufacturer's instructions (Miltenyi, Bergisch Gladbach, Germany) or a FACSAria flow cytometer (BD, San Jose, CA, USA) to sort these cell populations as described previously. 23 The sorted CD4 1 CD25
T-cell and CD4

CD25
2 T-cell populations had purities greater than 90% and 95%, respectively. The cell viability was typically greater than 95% as determined by trypan blue exclusion. 24 Freshly isolated 1310
T cells or both cells at a ratio of 1 : 1 were directly transferred into the allogeneic NOD-scid mouse peritoneal cavity.
Preparation of peritoneal macrophages
Mouse peritoneal exudate cells were obtained from the peritoneal exudates of mice as previously described. 17, 25, 26 Briefly, the peritoneal exudate cells were washed twice with cold Hanks' solution and adjusted to 5310 6 cells/ml in RPMI 1640 medium (Gibco BRL, Grand Island, NY, USA). The cells were cultured in 2% gelatin (Sigma, St Louis, MO, USA)-pretreated six-well plates (Costar, Cambridge, MA, USA) for 3-4 h at 37 uC and 5% CO 2 . The nonadherent cells were removed by washing with warm RPMI 1640 medium. The adherent cells were harvested with 5 mM EDTA (Sigma) in ice-cold phosphate-buffered solution (PBS, pH 7.2), and the cell density was adjusted to 1310 6 cells/ml. The purity of the isolated macrophages was typically .90% as determined by F4/80 1 cells, and the cell viability was typically greater than 95% as determined by trypan blue exclusion.
Immunofluorescence staining and flow cytometry (FCM)
The macrophages ( 5310 5 ) were washed once with FACS buffer (PBS, 0.1% NaN 3 and 0.5% bovine serum albumin, BSA). For three-color staining, the cells were stained with PE-labeled anti-F4/80 monoclonal antibody (mAb) and antigen-presenting cell-anti-CD11c monoclonal antibody (mAb) and either FITC-labeled anti-MHC II (M5), CD80 (16-10A1), CD86 (GL1), CD40 (3/23), CD54 (3E2), CD23 (B3B4), programmed cell death-ligand 1 (PD-L1; 1-111A), TLR2 (mT2.7) mAb, or the non-specific staining control mAb. Anti-mouse FcR mAb (2.4G2) was used prior to staining to block any non-specific FcR binding. At least 10 000 cells were assayed using a FASCalibur flow cytometer (Becton Dickinson, San Diego, CA, USA), and the data were analyzed with CellQuest software (San Jose, CA, USA). Non-viable cells were excluded using the vital nucleic acid stain, propidium iodide). Certain molecular expression levels were determined as the median fluorescence intensity (MFI) of the cells that were positively stained with the specific mAb. 24, 27 IFN-c, IL-4, IL-10 and IL-12 expression in the macrophages was detected using the BD Cytofix/Cytoperm Plus with GolgiPlug intracellular staining kits (BD Biosciences PharMingen, San Diego, CA, USA). The macrophages were stimulated with LPS (100 ng/ml) in six-well plates for approximately 18 h. During the last 4-6 h of culture, 1 ml aliquots of cells were pulsed with 1 mL BD GolgiPlug containing brefeldin A (BD Biosciences PharMingen). The macrophages were collected and washed once with FACS buffer. After incubation with the anti-FcR mAb (2.4G2) and FITC-conjugated anti-mouse F4/80 mAb in the dark at room temperature for 15 min, the cells were washed once with staining buffer and then fixed and permeabilized with 500 ml BD Cytofix/Cytoperm solution at room temperature in the dark for 20 min according to the manufacturer's instructions. Next, the cells were stained with either 0.25 mg PElabeled anti-IFN-c (GIR-208), IL-4 (11B11), IL-10 (JES5-16E3), IL-12 (C17.8), TNF-a (MP6-XT22) or IL-17A (eBio17B7) mAb for 30 min at room temperature in the dark and washed three times, and 10 000 F4/ 80 1 cells were then analyzed by FCM. 26, 28, 29 Arginase assay The arginase activity assay was performed as previously described. 30, 31 Briefly, the cells were lysed in 0.1% Triton X-100. Tris-HCl was then added to the cell lysates at a final concentration of 12.5 mM, and Table 1 The sequences of the primers used for real-time PCR assays
Genes Primers
Abbreviations: iNOS, inducible NO synthase; PD-L2, programmed cell death-ligand 2.
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MnCl 2 was added to obtain a 1 mM final concentration. The arginase was activated by heating for 10 min at 56 uC, and the L-arginine substrate was added at a final concentration of 250 mM. The reactions were incubated at 37 uC for 30 min and halted by the addition of H 2 SO 4 /H 3 PO 4 . After the addition of a-isonitrosopropiophenone and heating for 30 min at 95 uC, the urea production was measured as the absorbance at 540 nm, and the data were normalized to the total protein content.
Nitric oxide (NO) production NO production by the macrophages was determined by measurement of the nitrite concentration with the Griess assay. 32, 33 The supernatants (100 ml) were added to 100 ml of a 1 : 1 mixture of 1% sulfanilamide dihydrochloride (Sigma) and 0.1% naphthyl ethylenediamine dihydrochloride (Sigma) in 2.5% H 3 PO 4 . The plates were incubated at 37 uC for 10 min, and the absorbance at 550 nm was measured with a microplate reader (Molecular Devices, Sunnyvale, CA, USA). The nitrite concentration was calculated with a sodium nitrite standard curve as reported previously. 28 
Detection of IFN-c, IL-4 and IL-10
The levels of IFN-c, IL-4 and IL-10 in the mouse sera were determined by specific enzyme-linked immunosorbent assay kits (R&D) 3 days after the adoptive transfer of CD4 1 CD25 1 Tregs or CD4 1 CD25 2 T cells into the NOD-scid mice.
Mixed lymphocyte reaction (MLR) CD4
1 T cells were purified by the negative selection of BALB/c mouse splenocytes using a mouse CD4
1 T lymphocyte enrichment set (BD Biosciences PharMingen). CD4
1 T responders (2310 5 ) and macrophage stimulators (1310 5 ), which were pre-treated with 50 mg/mL mitomycin C, were incubated in triplicate in 0.2 mL medium in Ubottomed 96-well microplates (Costar) at 37 uC in 5% CO 2 . 18, 28, 34, 35 The plates were pulsed with 1 mCi of 3 H-labeled thymidine (radioactivity, 185 GBq/mM; Atomic Energy Research Establishment, Beijing, China) per well on day 3, and after 18 h of further incubation, the cells were harvested onto glass fiber filters with an automatic cell harvester (Tomtec, Toku, Finland). The samples were assayed in a . The values were expressed as the counts per minute from the triplicate wells and are the results after subtracting the counts per minute from wells without stimulants. 36 
Phagocytosis of chicken red blood cells (cRBCs) in vivo
A single-cell suspension of cRBCs was freshly obtained. After two washes with PBS, 1310 7 cells/mL cRBCs were labeled with 5 mM 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR, USA) for 15 min at 37 uC. These cells were then washed thoroughly and re-suspended at a concentration of 1310 7 cells/ml. Cell viability was typically greater than 95%. A suspension of CFSE-labeled cRBCs (1 ml) was injected into the peritoneal cavity of the NOD-scid mice 3 days after the adoptive transfer of no cells, CD4
1 CD25 1 T cells or CD4 1 CD25 2 T cells. At 6-10 h after the injection of the cRBCs, the F4/80 1 macrophages were collected as described above. The cells were first stained with anti-mouse FccR mAb (2.4G2) to block any nonspecific staining and then stained with PE-conjugated anti-F4/80 mAb. After three washes with FACS buffer, the phagocytosis percentage of the F4/80 1 cells was determined by FCM. In parallel, a portion of the peritoneal macrophages was spotted onto coverslips. As reported previously, 34, 37 the adherent cells were stained with Giemsa stain and Wright staining solution (Sigma) after fixation in methanol.
Quantitative RT-PCR RNA was extracted with an RNeasy kit (Qiagen, Valencia, CA, USA), and the cDNA was synthesized with SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA). An ABI 7900 Real-Time PCR system was used for the quantitative PCR with primer and probe sets from Applied Biosystems. The probe sets were as follows: IL-23, PD-L2, ICOSL, CXCL9, CXCL10, CCL22, inducible NO synthase (iNOS) and Arginase I. The results were analyzed with SDS 2.1 software. The cycling threshold value of the endogenous control gene, Hprt1, which encodes for hypoxanthine guanine phosphoribosyl transferase, was subtracted from the cycling threshold value of each target gene to generate the change in cycling threshold. The expression of each target gene is presented as the fold change relative to the control samples. The sequences of the primers used for the real-time PCR assays are summarized in Table 1 .
Statistical analysis
All data are presented as the mean6s.d. The Student's unpaired t-test for the comparison of means was used to compare the groups. A P value less than 0.05 is considered to be statistically significant. ). Three days after the adoptive transfer of these cells, the percentages of F4/80 1 macrophages expressing CD80, CD86, CD40 or MHC II were significantly increased in the mice that received the allogeneic CD4 1 CD25
RESULTS
Allogeneic donor CD4
2 Teffs compared to the control mice that did not receive any cells. However, the percentages of peritoneal resident F4/80 1 macrophages in the recipient mice expressing CD80, CD86, CD40 or MHC II molecules were significantly decreased in the NOD-scid mice that received the allogeneic CD4 1 CD25 1 Tregs compared to the mice that received either no cells or the CD4 1 CD25 2 Teffs (P,0.01, Figure 1 ). The MFIs of CD80, CD40 and MHC II but not CD86 were significantly decreased in the NOD-scid mice that received the allogeneic CD4 1 CD25 1 Tregs compared to the mice that received either no cells or the CD4 1 CD25 2 Teffs (Figure 1 ). The percentages of macrophages expressing CD54 and the MFI of CD54 expression on the macrophages were comparable for all the treated groups. Notably, the percentages of Figure 1) . However, there was no difference in PD-L2 expression in the macrophages isolated from the mice that received either the CD4 Figure 1) . Furthermore, TLR2 expression was also significantly increased in the mice that received the CD4 1 CD25 1 Tregs and the CD4 1 CD25 2 Teffs compared to the control mice that did not receive cells. TLR4 expression on the macrophages was identical among these groups (data not shown). Importantly, the allogeneic donor CD4
M2 macrophages induced by allogeneic CD4
1
CD25
1 Tregs efficiently reversed the allogeneic donor CD4 1 CD25
2
Teffs-induced upregulation of CD80, CD86, CD40 and MHC II expression (Figure 1b and c) . Additionally, an identical observation was obtained with respect to the MFI value of the costimulatory molecule expression levels. These data indicate that the distinct phenotypes of the recipient mouse macrophages were induced by the allogeneic donor CD4 Tregs, CD4 1 CD25 2 Teffs or both cells (1 : 1) was detected by FCM or microscopy as described in the section on 'Materials and methods'. As shown in Figure 2 , the F4/80 1 macrophages in the mice that received the allogeneic donor CD4 1 CD25 1 Tregs exhibited significantly higher rates of phagocytosis of the cRBCs than the mice that received either the CD4 2 Teffs was also observed with respect to the regulation of macrophage phagocytosis. Notably, the absolute numbers of macrophages in the peritoneal cavity were identical in all the mice (P.0.05, Figure 2e ).
Allogeneic donor CD4
1 CD25 1 Tregs inhibited the immunogenicity of the recipient mouse macrophages Macrophages play a critical role in the initiation of the adaptive immune response. Macrophages are isolated from the peritoneal cavity and the purity is confirmed by FCM as shown in Figure 3a . The immunogenicity of the F4/80 1 macrophages that were separated from the NOD-scid mice that received the allogeneic CD4 1 CD25
1
Tregs or CD4 1 CD25 2 Teffs or both cells (1 : 1) was investigated in vitro. As shown in Figure 3a , there was significantly decreased immunogenicity of the F4/80 1 macrophages that were separated from the NOD-scid mice that received the allogeneic CD4 1 CD25 1 Tregs to the allogeneic T cells compared to the macrophages from the mice that received either the CD4 1 CD25 2 Teffs or no cells. This result was determined by MLR assays (P,0.01, Figure 3a) . However, the allogeneic CD4 1 CD25 2 Teffs somewhat increased the immunogenicity of the macrophages to the allogeneic T cells compared to the mice that did not receive cells (P,0.01, Figure 3a) .
In addition, the cytokine expression of the macrophages was analyzed. As shown in Figure 3b , the peritoneal F4/80 1 macrophages in the recipient mice that received the allogeneic CD4 1 CD25 1 Tregs exhibited significantly higher IL-10 expression levels than the mice that received either the CD4 1 CD25 2 T cells or no cells (P,0.01).
The F4/80 1 macrophages in the recipient mice that received the allogeneic donor CD4 1 CD25 2 Teffs showed higher levels of IFN-c, IL-12 and TNF-a but not IL-17A; however, the allogeneic donor CD4 1 CD25 1 Tregs did not significantly alter the secretion of these cytokines (P,0.01, Figure 3b ). IL-4 production by the F4/80 1 macrophages was similar among these groups (Figure 3b and f) . The IFN-c, IL-12 and TNF-a but not IL-17A production by the F4/80 1 macrophages induced by the allogeneic CD4 1 CD25 2 Teffs was inhibited by the cotransfer of allogeneic CD4
1 CD25 1 Tregs (P,0.01, Figure 3b) . The mRNA expression level of IL-23 in the macrophages isolated from the mice that received either the allogeneic CD4 1 CD25 1 Tregs or CD4 1 CD25 2 Teffs was higher than in the mice that did not receive T cells. The allogeneic CD4 1 CD25 2 Teffs induced more IL-23 production than the CD4 1 CD25 1 Tregs (P,0.01, Supplementary  Figure 2) . The recipient mouse serum cytokine levels were also investigated using enzyme-linked immunosorbent assays 3 days after the adoptive transfer of the T cells. Consistently, the recipient mice that received the allogeneic donor CD4 
and higher IL-10 levels compared to the mice that received either the CD4 1 CD25 2 T cells or no cells (P,0.01, Figure 3d and e). The IL-4 levels in the sera of the recipient mice were identical regardless of whether the mice received T cells or not. The M1-associated chemokine genes, CXCL10 and CXCL9, are significantly increased in the macrophages isolated from the mice that received the CD4 1 CD25
2 Teffs compared to the control mice or the mice that received the CD4 1 CD25 1 Tregs (P,0.01, Figure 3g ). The M2-associated chemokine gene, CCL22, was not significantly different among these mice.
Allogeneic donor CD4
1 Foxp3 1 Tregs induced functional stable macrophages in recipient mice To investigate the functional stability of the changes in the recipient mouse macrophages that were induced by the allogeneic CD4
1 Foxp3 1 Tregs, we used a Foxp3-GFP knock-in mice. The CD4 1 Foxp3 1 Treg and CD4 1 Foxp3 2 T cells in the periphery were sorted from these mice and the purity was determined by FCM (Figure 4a ). Seven to eight days after the cells were transferred into the recipient mice, the immunogenicity of the recipient mouse peritoneal macrophages was investigated. The results showed that there was significantly decreased immunogenicity to the allogeneic T cells of the F4/80 1 macrophages isolated from the NOD-scid mice that received the CD4 1 CD25 1 Tregs compared to the mice that received either the CD4 1 CD25 2 Teffs or no cells (Figure 4b ). This finding suggests that the recipient macrophages that were induced by the CD4 1 CD25 1 Tregs displayed stable functional characteristics in vivo for at least 1 week.
1 CD25 1 Tregs induced M2-like macrophages in recipient mice Depending on the activating stimuli, macrophages can either develop into M1 or M2 macrophage subsets. L-arginine metabolism is an important branch point in this differential activation that leads to the development of either M2 or M1 macrophages. Therefore, the production of NO and arginase by the macrophages in this models was investigated. As shown in Figure 5 , F4/80 1 macrophages of the recipient mice that received the CD4 1 CD25 1 T cells showed significantly higher arginase activity and lower NO production than the mice that received either the allogeneic CD4
1 CD25 2 T cell or no cells (P,0.01, Figure 5a and b) . Consistently, the mRNA analysis showed higher arginase I and lower iNOS mRNA expression levels in the recipient F4/80 1 macrophages of the mice that received the CD4 Tregs in the NOD-scid mice ( Figure 6 ). These data demonstrate that the development of recipient M2-like macrophages that is induced by the allogeneic donor CD4 1 CD25 1 Tregs is dependent on the arginase pathway.
DISCUSSION
The functional polarization of macrophages into M1 or M2 cells is a simplified conceptual framework that describes the plasticity of mononuclear phagocytes. 35, 38, 39 As demonstrated by our studies and those of others, syngeneic CD4 1 CD25 1 Tregs have been shown to be critical for the induction of the macrophage phenotype switch both in vivo and in vitro. 14, 15 In this study, the allogeneic donor CD4 1 CD25 It has been reported that M2 macrophages may be induced by IL-10, TGF-b, IL-4 or/and IL-13.
30,40-42 M2 macrophages produce high levels of arginase I, which efficiently converts L-arginine into urea and ornithine. 3, 4 In this model, the recipient resident macrophages expressed high levels of IL-10 and low levels of IFN-c, IL-12 and TNF-a when the mice received the allogeneic donor CD4 1 CD25 1 Tregs cells, whereas injection of allogeneic donor CD4 1 CD25 2 Teffs caused the recipient macrophages to produce more IFN-c, IL-12 and TNF-a in the NOD-scid mice. Furthermore, the enhanced phagocytosis and decreased antigenpresenting ability of the host resident macrophages that were induced by the allogeneic donor CD4 1 CD25 1 Tregs could be rescued by the arginase inhibitor, BEC, in vivo. [7] [8] [9] 11, 30, 43, 44 These data provide metabolic enzyme evidence for the presence of polarized recipient M2-like macrophages and further suggest that the induction of M2-like macrophages by donor allogeneic CD4 1 CD25 1 Tregs is significantly dependent on arginase signaling pathways.
In summary, allogeneic donor CD4 1 CD25 1 Tregs could directly induce a phenotypic and functional switch of the recipient resident macrophages in vivo, which is distinct from the allogeneic donor CD4
1 Teffs. In this study, our data offer direct evidence to support the fact that allogeneic donor CD4 1 CD25 1 Tregs induce host M2-like macrophage polarity, whereas allogeneic CD4
1 Teffs promote host M1-like macrophages in vivo, which is dependent on the arginase signaling pathway. Therefore, this evidence indicates that either allogeneic donor or recipient CD4
1 T cell subsets may mediate the reciprocal induction pathways for recipient or graft M1 and M2 macrophages. The antagonistic effects of donor allogeneic CD4 
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